Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses
These results suggest that genotyping for common CYP3A variants might have the potential to guide benzodiazepine withdrawal treatment. The effect of of the 1846G>A polymorphism of CYP2D6 gene on the safety profile of haloperidol was demonstrated in a group of 100 patients with alcoholic hallucinoses.
Authors
- I A Zaytsev
- К. А. Акмалова (ORCID: https://orcid.org/0000-0003-3505-8520)
- Н. П. Денисенко (ORCID: https://orcid.org/0000-0003-3278-5941)
- M. S. Zastrozhin (ORCID: https://orcid.org/0000-0003-0607-4812)
- Evgeny Bryun (ORCID: https://orcid.org/0000-0002-9329-1155)
- V A Ivanchenko
- S A Pozdniakov
- V V Noskov
- Valentin Yurievich Skryabin (ORCID: https://orcid.org/0000-0002-4942-8556)
- Dmitry Alekseevich Sychev (ORCID: https://orcid.org/0000-0002-4496-3680)
- A A Parkhomenko (ORCID: https://orcid.org/0000-0002-3332-1033)
Institutions
- Moscow Clinical Scientific Center (RU)
- Russian Medical Academy of Continuous Professional Education (RU)
- Research Center of Neurology (RU)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-08-12
- DOI
- https://doi.org/10.64719/pb.4444
- Citations
- 3
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47